Who has been buying Amicogen stock?

6 distinct insiders have filed 11 disclosed insider purchases in Amicogen (092040), most recently on 2026-04-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Amicogen have?

Amicogen has 11 buy-side and 4 sell-side disclosures on record, covering ₩10.6B ($7.3M) in total reported value, spanning 2023-12-12 to 2026-04-27.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Amicogen 092040

Company

아미코젠Amicogen

Insiders

Buys

Total Value

₩10.6B ($7.3M)

Avg Return

-24.63%

Last Filing

2026-04-27

Amicogen (092040) has 11 disclosed insider purchases and 4 disclosed disposals on record, filed by 6 distinct insiders. Together those filings cover ₩10.6B ($7.3M) in reported transaction value. The earliest filing StockDrifts holds for Amicogen is dated 2023-12-12; the most recent is 2026-04-27. Across these filings the average return since disclosure is -24.63%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-09-01	BUY	Market Buy	소지성 Sojiseong	Internal director	10.0K	₩1,011	+0.2%	₩10M ($7K)
2026-08-07	BUY	Market Buy	소지성 Sojiseong	Internal director	4.3K	₩1,024	+4.0%	₩4M ($3K)
2026-04-27	SELL	기타	소지성 Sojiseong	Internal director	-100.0K	₩1,913	+13.5%	₩191M ($133K)
2026-02-26	BUY	유상신주취득	윤영철 Youngcheol Yoon	Internal director	109	-	-	-
2026-02-26	BUY	유상신주취득	소지성 Sojiseong	Internal director	435	-	-	-
2026-02-24	BUY	Market Buy	황은성 Hwang Eun-seong	Managing Director	4.0K	-	-	-
2025-09-18	BUY	Market Buy	박철 Park Cheol	CEO	2.5K	₩3,910	-60.2%	₩10M ($7K)
2025-09-17	BUY	Market Buy	윤영철 Youngcheol Yoon	Internal director	3.0K	₩3,855	-59.6%	₩12M ($8K)
2025-07-18	BUY	Market Buy	김준호 Junho Kim	vice president	2.0K	₩4,240	-63.3%	₩8M ($6K)
2025-06-25	BUY	Market Buy	황은성 Hwang Eun-seong	Managing Director	5.6K	₩3,700	-58.0%	₩21M ($14K)
2025-03-18	BUY	Market Buy	박철 Park Cheol	CEO	2.5K	₩3,625	-57.1%	₩9M ($6K)
2025-03-18	BUY	신규보고	윤영철 Youngcheol Yoon	Internal director	858	₩3,625	-57.1%	₩3M ($2K)
2025-03-18	BUY	Market Buy	윤영철 Youngcheol Yoon	Internal director	3.0K	₩3,625	-57.1%	₩11M ($8K)
2025-03-18	BUY	Market Buy	소지성 Sojiseong	Internal director	6.0K	₩3,625	-57.1%	₩22M ($15K)
2025-03-12	BUY	Market Buy	김준호 Junho Kim	vice president	8.3K	₩3,500	-55.5%	₩29M ($20K)
2025-02-27	SELL	Market Sell	신용철 Shin Yong-cheol	Chairman	-811.0K	₩4,350	+64.2%	₩3.5B ($2.4M)
2025-02-26	SELL	Market Sell	신용철 Shin Yong-cheol	Chairman	-500.0K	₩4,650	+66.5%	₩2.3B ($1.6M)
2025-02-26	BUY	신규선임	소지성 Sojiseong	Internal director	220.0K	₩4,650	-66.5%	₩1.0B ($710K)
2025-02-25	SELL	Market Sell	신용철 Shin Yong-cheol	Chairman	-835.2K	₩4,085	+61.9%	₩3.4B ($2.4M)
2025-02-24	SELL	Market Sell	신용철 Shin Yong-cheol	Chairman	-258.4K	₩3,700	+58.0%	₩956M ($664K)
2025-02-24	BUY	Market Buy	김준호 Junho Kim	vice president	5.4K	₩3,700	-58.0%	₩20M ($14K)
2024-08-01	BUY	신규선임	전병우 Jeon Byeong-woo	president	9.8K	₩5,080	-69.4%	₩50M ($34K)
2024-07-01	BUY	Market Buy	신용철 Shin Yong-cheol	Chairman	39.2K	₩5,130	-69.7%	₩201M ($140K)
2023-12-14	BUY	무상신주취득	박철 Park Cheol	CEO	89.4K	₩7,000	-77.8%	₩625M ($434K)
2023-12-12	BUY	무상신주취득	신용철 Shin Yong-cheol	Chairman	3.4M	₩6,940	-77.6%	₩23.9B ($16.6M)

Frequently asked questions

Who has been buying Amicogen stock?: 6 distinct insiders have filed 11 disclosed insider purchases in Amicogen (092040), most recently on 2026-04-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Amicogen have?: Amicogen has 11 buy-side and 4 sell-side disclosures on record, covering ₩10.6B ($7.3M) in total reported value, spanning 2023-12-12 to 2026-04-27.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.